• header-downloads

    DOWNLOADS


Download the latest posters and presentations.

Learn more about the latest research for treating patients with CML and ALL by downloading the summary of Incyte Bioscience’s most recent clinical research presented at ASH 2016.

Title First Author Presentation form Date and Time Download posters and presentations
Analysis of the Sub-Clonal Origins of Compound Mutations in Patients with Refractory Ph+ Malignancies Treated with Ponatinib Justin R. Pritchard Oral Monday, December 5
05.30 PM
Ponatinib in Chronic-Phase Chronic Myeloid Leukemia Patients: Final Report from a Phase 1 Trial Michael J. Mauro Poster Presentation Sunday, December 4
6.00 PM – 8.00 PM
Long-Term Follow-up of the Efficacy and Safety of Ponatinib in Philadelphia Chromosome-Positive Leukemia Patients with the T315I Mutation Elias J. Jabbour Poster Presentation Sunday, December 4
6.00 PM – 8.00 PM
Predictors of Ponatinib Therapy Duration Among Real-World Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients in the US Michael J. Mauro Poster Presentation Sunday, December 4
6.00 PM – 8.00 PM
Meta-Analysis and Meta-Regression of the Efficacy of Front-Line Treatment Combinations with Ponatinib Versus 1st- and 2nd-Generation Tyrosine Kinase Inhibitors for Ph+ Acute Lymphoblastic Leukemia Elias J. Jabbour Publication Availalbe online only